DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 913 filers reported holding DANAHER CORPORATION in Q2 2014. The put-call ratio across all filers is 0.24 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,888 | +6.5% | 55,000 | 0.0% | 2.07% | +10.6% |
| Q2 2023 | $12,099 | -5.2% | 55,000 | 0.0% | 1.87% | -12.0% |
| Q1 2023 | $12,759 | +4.7% | 55,000 | +12.2% | 2.13% | -10.8% |
| Q4 2022 | $12,186 | -99.9% | 49,000 | -14.0% | 2.39% | -11.6% |
| Q3 2022 | $15,028,000 | -1.6% | 57,000 | -9.5% | 2.70% | +5.1% |
| Q2 2022 | $15,277,000 | -17.2% | 63,000 | -10.0% | 2.57% | +8.4% |
| Q1 2022 | $18,454,000 | -20.3% | 70,000 | -12.5% | 2.37% | -6.8% |
| Q4 2021 | $23,145,000 | +10.1% | 80,000 | 0.0% | 2.54% | +1.6% |
| Q3 2021 | $21,015,000 | +3.2% | 80,000 | -11.1% | 2.50% | +3.8% |
| Q2 2021 | $20,366,000 | +18.2% | 90,000 | 0.0% | 2.41% | +12.4% |
| Q1 2021 | $17,236,000 | +582.6% | 90,000 | +205.7% | 2.15% | +658.3% |
| Q3 2017 | $2,525,000 | +1.7% | 29,437 | 0.0% | 0.28% | -3.7% |
| Q2 2017 | $2,484,000 | +128.7% | 29,437 | +131.8% | 0.29% | +124.4% |
| Q1 2017 | $1,086,000 | +9.8% | 12,700 | 0.0% | 0.13% | +2.3% |
| Q4 2016 | $989,000 | -0.7% | 12,700 | 0.0% | 0.13% | 0.0% |
| Q3 2016 | $996,000 | -22.4% | 12,700 | 0.0% | 0.13% | -26.0% |
| Q2 2016 | $1,283,000 | +6.5% | 12,700 | 0.0% | 0.17% | -0.6% |
| Q1 2016 | $1,205,000 | -23.2% | 12,700 | -24.9% | 0.17% | -13.9% |
| Q4 2015 | $1,570,000 | +9.0% | 16,900 | 0.0% | 0.20% | +6.9% |
| Q3 2015 | $1,440,000 | -0.4% | 16,900 | 0.0% | 0.19% | +7.4% |
| Q2 2015 | $1,446,000 | +0.8% | 16,900 | 0.0% | 0.18% | +6.0% |
| Q1 2015 | $1,435,000 | +24.0% | 16,900 | +25.2% | 0.17% | +17.7% |
| Q4 2014 | $1,157,000 | +12.8% | 13,500 | 0.0% | 0.14% | +11.0% |
| Q3 2014 | $1,026,000 | -3.5% | 13,500 | 0.0% | 0.13% | -7.3% |
| Q2 2014 | $1,063,000 | +4.9% | 13,500 | 0.0% | 0.14% | -4.2% |
| Q1 2014 | $1,013,000 | -2.8% | 13,500 | 0.0% | 0.14% | -11.2% |
| Q4 2013 | $1,042,000 | +11.4% | 13,500 | 0.0% | 0.16% | +7.3% |
| Q3 2013 | $935,000 | +9.5% | 13,500 | 0.0% | 0.15% | +2.7% |
| Q2 2013 | $854,000 | – | 13,500 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |